CCL5 and neoplasm: A similar reduction of GZMB/CCL5-expressing CD4+ TILs was observed when a comparison was made between 1956 tumour-bearing WT mice and mice with a targeted disruption of the Lilrb4 gene (Extended Data Fig. 6f).